4.6 Article

Schwann cells-derived exosomes promote functional recovery after spinal cord injury by promoting angiogenesis

Journal

FRONTIERS IN CELLULAR NEUROSCIENCE
Volume 16, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2022.1077071

Keywords

Schwann cells; exosomes; angiogenesis; integrin-beta 1; spinal cord injury

Categories

Ask authors/readers for more resources

This study demonstrates that Schwann cells-derived exosomes (SCs-Exos) can promote proliferation, migration, and tube formation of brain-derived endothelial cells (bEnd.3 cells). It is found that SCs-Exos express high levels of the pro-angiogenesis molecules, Integrin-beta 1. The angiogenic effect of SCs-Exos on bEnd.3 cells is dependent on Integrin-beta 1 expression. In an spinal cord injury (SCI) model, treatment with SCs-Exos attenuates tissue damage and enhances functional recovery by promoting angiogenesis, which requires the involvement of Integrin-beta 1.
Exosomes are small vesicles that contain diverse miRNA, mRNA, and proteins that are secreted by multiple cells, and play a vital function in cell-cell communication. Numerous exosomes produced by cells have been demonstrated to be protective against spinal cord injury (SCI). This study aims to investigate the neuroprotective effect of Schwann cells-derived exosomes (SCs-Exos) on spinal cord injury. We found that SCs-Exos can be taken directly by brain-derived endothelial cells.3 (bEnd.3 cells) and promoted to proliferate, migrate, and form bEnd.3 tube. Additionally, our results showed that the pro-angiogenesis molecules, Integrin-beta 1, were highly expressed in SCs-Exos. Moreover, we used special shRNA technology to investigate the role of Integrin-beta 1 in mediating the effect of SCs-Exos-induced angiogenesis on bEnd.3 cells. We observed that the pro-angiogenic effect of SCs-Exos on bEnd.3 cells was suppressed by inhibiting the expression of integrin-beta 1 in SCs-Exos. In the SCI model, we found that SCs-Exos attenuated tissue damage and improved functional recovery after SCI. Using immunofluorescence staining, we observed that SCs-Exos treatment promoted angiogenesis in SCI, and integrin-beta 1 was required to promote angiogenesis. In conclusion, our results indicate that SCs-Exos promote angiogenesis by delivering integrin-beta 1 and may serve as a promising novel therapeutic agent for enhancing neurological functional recovery after SCI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available